Excelsior Biopharma (ROCO:6496) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6496 Excelsior Biopharma Inc ROCO:6496
53 GF Score
Price NT$24.60
GF Value NT$34.14
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Excelsior Biopharma FFO per Share?

FFO per Share only applies to REITs.

ROCO:6496
53GF Score
Excelsior Biopharma Inc ROCO:6496
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Excelsior Biopharma (ROCO:6496) Overvalued in 2026?

Based on GuruFocus' analysis, Excelsior Biopharma stock appears to be undervalued. The current stock price of NT$24.60 is trading 27.9% below its estimated GF Value™ of NT$34.14. GuruFocus considers Excelsior Biopharma to be Modestly Undervalued.

Key valuation signals for ROCO:6496:

  • FFO per Share:
  • GF Value™: NT$34.14 vs. price of NT$24.60 (27.9% below fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6496 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Excelsior Biopharma Business Description

Address Zhongxiao E. Road, 5Floor, No.508, Sector 7, Nangang District, Taipei, TWN, 11561
Excelsior Biopharma Inc is mainly engaged in western medicines, importing and exporting of Active Pharmaceutical Ingredients, food, cosmecteuticals and development of cosmetics, research, importing, and exporting of technologies, pharmaceutical technologies transfer and cooperative development and improvement. Geographically, it derives revenue from Taiwan, China and others, with majority of revenue earned from Taiwan.
53GF Score

Get the complete analysis for ROCO:6496

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$24.60
Price
NT$34.14
GF Value